Neasa Hourigan (Dublin Central, Green Party) | Oireachtas source

I will turn to AstraZeneca if I have time. Last week, when the committee discussed matters, the changes in the advice around the AstraZeneca vaccine had come through. As I understand it, the current advice is that we will continue with AstraZeneca with the older cohort and those in a vulnerable position or at high risk but as in other EU countries, those who are not in those cohorts and have received their first dose may begin a new course or receive a new vaccine or at least wait 16 weeks before they go ahead. Could somebody outline that in greater detail? What percentage of people are in that cohort and might have their second dose disrupted or might be looking at a different vaccine?